Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04781075 · ClinicalTrials.gov registry record · Phase 4

Modified TAP (Transverse Abdominis Plane) Block in Colorectal Surgery

A Phase 4 study, sponsored by Ochsner Health System.

Completed
Registry status
Phase 4
Development phase
76
Enrollment target

NCT04781075: Completed Phase 4 study, sponsored by Ochsner Health System.

NCT04781075 is a Phase 4 study that has completed, run by Ochsner Health System. The registered enrollment target is 76 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04781075, a Phase 4 study, has completed, sponsored by Ochsner Health System.

COMPLETED
Registry status
Phase 4
Development phase
76 participants
Enrollment target

Study Summary

Single Blind, Randomized Controlled study to see if TAP Block with Exparel provides better pain relief than TAP Block with bupivicaine. Differences in Pain Scale, Length of Stay, and Total Narcotic use in the hospital will be evaluated.

Primary Outcome

Daily Pain Scale using Wong-baker FACES Pain Rating Scale 0 (no pain) - 10 (worst pain imaginable)

Interventions

  • DRUG Bupivacaine Injection
  • DRUG Exparel Injectable Product
  • OTHER Pain Scale

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2017-12-01
Est. Completion 2021-07-31
Phase Phase 4
Ochsner Health System

29 total trials

What the finished NCT04781075 record still lists

NCT04781075 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 3 interventions - of which Bupivacaine Injection is the first listed.

NCT04781075 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04781075 about?

NCT04781075 is a clinical study titled "Modified TAP (Transverse Abdominis Plane) Block in Colorectal Surgery". Single Blind, Randomized Controlled study to see if TAP Block with Exparel provides better pain relief than TAP Block with bupivicaine. Differences in Pain Scale, Length of Stay, and Total Narcotic use in the hospital will be evaluated.

What is the current status of trial NCT04781075?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 76 participants. The study started on 2017-12-01. Estimated completion is 2021-07-31.

What interventions are being tested in trial NCT04781075?

The interventions under investigation include: Bupivacaine Injection (DRUG), Exparel Injectable Product (DRUG), Pain Scale (OTHER).

Who is sponsoring clinical trial NCT04781075?

This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04781075's enrollment target sits among peer trials

76 994th of 2000 higher than 999 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04781075, the US trial registry maintained by the National Library of Medicine. NCT04781075 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.